1. Home
  2. LQDA vs STC Comparison

LQDA vs STC Comparison

Compare LQDA & STC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LQDA
  • STC
  • Stock Information
  • Founded
  • LQDA 2004
  • STC 1893
  • Country
  • LQDA United States
  • STC United States
  • Employees
  • LQDA N/A
  • STC N/A
  • Industry
  • LQDA Biotechnology: Pharmaceutical Preparations
  • STC Specialty Insurers
  • Sector
  • LQDA Health Care
  • STC Finance
  • Exchange
  • LQDA Nasdaq
  • STC Nasdaq
  • Market Cap
  • LQDA 2.5B
  • STC 2.1B
  • IPO Year
  • LQDA 2018
  • STC N/A
  • Fundamental
  • Price
  • LQDA $32.15
  • STC $77.95
  • Analyst Decision
  • LQDA Strong Buy
  • STC Buy
  • Analyst Count
  • LQDA 10
  • STC 2
  • Target Price
  • LQDA $37.40
  • STC $77.50
  • AVG Volume (30 Days)
  • LQDA 2.7M
  • STC 166.0K
  • Earning Date
  • LQDA 11-03-2025
  • STC 10-22-2025
  • Dividend Yield
  • LQDA N/A
  • STC 2.79%
  • EPS Growth
  • LQDA N/A
  • STC 69.60
  • EPS
  • LQDA N/A
  • STC 3.60
  • Revenue
  • LQDA $69,216,000.00
  • STC $2,796,513,000.00
  • Revenue This Year
  • LQDA $424.31
  • STC $17.67
  • Revenue Next Year
  • LQDA $359.32
  • STC $10.14
  • P/E Ratio
  • LQDA N/A
  • STC $20.89
  • Revenue Growth
  • LQDA 343.41
  • STC 16.09
  • 52 Week Low
  • LQDA $10.37
  • STC $56.39
  • 52 Week High
  • LQDA $32.41
  • STC $78.61
  • Technical
  • Relative Strength Index (RSI)
  • LQDA 70.67
  • STC 69.03
  • Support Level
  • LQDA $27.76
  • STC $70.86
  • Resistance Level
  • LQDA $30.50
  • STC $73.62
  • Average True Range (ATR)
  • LQDA 1.85
  • STC 2.32
  • MACD
  • LQDA 0.36
  • STC 0.59
  • Stochastic Oscillator
  • LQDA 98.23
  • STC 92.50

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About STC Stewart Information Services Corporation

Stewart Information Services Corp is a customer-focused, title insurance and real estate services company offering products and services to home buyers and sellers, mortgage lenders and servicers, attorneys, and home builders. It has three operating segments; Title insurance and related services which generates key revenue, includes the functions of searching, examining, closing, and insuring the condition of the title to real property. It also includes home and personal insurance services, Real estate solutions segment supports the real estate mortgage industry by providing appraisal management services, online notarization and closing solutions, credit, and real estate information services, search and valuation services. Corporate and other segment is comprised of parent holding company.

Share on Social Networks: